This week, PharmaShots’ news was all about the updates on Clinical Trials, Regulatory, Pharma, MedTech, M&A, Animal Health, and Biosimilars. Check out our full report below:
Daiichi Sankyo and Merck Report the P-II Study Data for Raludotatug Deruxtecan in Pt.-Resistant Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
Read More: Daiichi Sankyo and Merck
Gilead Highlights P-III (ASCENT-03) Trial Data of Trodelvy for Triple-Negative Breast Cancer (TNBC) at ESMO 2025
Read More: Gilead
Novartis Reports Cosentyx P-III trial met 1 & 2 EPs for Patients with Polymyalgia Rheumatica (PMR)
Read More: Novartis
Sanofi Reports P-II (ElevAATe) Trial Data on Efdoralprin Alfa for Alpha-1 Antitrypsin Deficiency (AATD) Emphysema
Read More: Sanofi
Regeneron Reports the CHMP’s Positive Opinion for Adjuvant Libtayo to Treat High-Risk Cutaneous Squamous Cell Carcinoma (CSCC)
Read More: Regeneron
Insmed’s Brinsupri (Brensocatib) Receives the CHMP’s Positive Opinion to Treat Non-Cystic Fibrosis Bronchiectasis (NCFB)
Read More: Insmed
Genentech Reports the US FDA’s Approval of Gazyva (Obinutuzumab) to Treat Lupus Nephritis
Read More: Genentech
Glaukos Receives FDA Approval for Epioxa
Read More: Glaukos
Sanofi’s Wayrilz (Rilzabrutinib) Receives the CHMP’s Positive Opinion to Treat Immune Thrombocytopenia (ITP)
Read More: Sanofi
GSK’s Shingrix PFS Presentation Receives the CHMP’s Positive Opinion
Read More: GSK
AstraZeneca and Amgen’s Tezspire (Tezepelumab) Secures the EU Approval for Severe Chronic Rhinosinusitis with Nasal Polyps (CRSwNP)
Read More: AstraZeneca & Amgen
GSK’s Blenrep (Belantamab Mafodotin) Regimen Receives the US FDA’s Approval to Treat R/R Multiple Myeloma
Read More: GSK
Boehringer Ingelheim Reports the NMPA’s Approval of Jascayd (Nerandomilast) for Idiopathic Pulmonary Fibrosis
Read More: BI
Samsung Bioepis and Phrontline Sign Global Strategic Partnership to Develop Advanced ADC Therapies for Solid Tumors
Read More: Samsung Bioepis & Phrontline
Taiho Pharmaceutical Secures Exclusive Licensing Rights for Casdatifan from Arcus Biosciences in Japan and Select Asian Territories
Read More: Taiho Pharmaceutical & Arcus Biosciences
Takeda Partners with Innovent Biologics to Boost Oncology Pipeline with Advanced Solid Tumor Therapies
Read More: Takeda & Innovent Biologics
Ventus Therapeutics Partners with Genentech to Develop Small-Molecule Drugs Using ReSOLVE Platform
Read More: Ventus Therapeutics & Genentech
Alife Health Receives CE Mark for Embryo Predict AI Embryo Selection Tool
Read More: Alife Health
Boston Scientific to Acquire Nalu Medical for ~$533M
Read More: Boston Scientific & Nalu Medical
Ipsen Acquires ImCheck Therapeutics, Enhancing its Oncology Leadership and Strengthening its Pipeline
Read More: Ipsen & ImCheck Therapeutics
Alkermes to Acquire Avadel Pharmaceuticals for ~$2.1B, Marking its Entry in Sleep Medicine Market
Read More: Alkermes and Avadel Pharmaceuticals
Teva and Prestige Biopharma Sign a Licensing Agreement to Commercialize Tuznue (Biosimilar, Herceptin) Across the EU
Read More: Teva and Prestige Biopharma
Polpharma Biologics Launches Ranivisio PFS (Biosimilar, Lucentis) in the EU
Read More: Polpharma Biologics
Merck Animal Health Reports Data on Bovillis Nasalgen-C Vaccination Against Bovine Coronavirus at Vlaamse Buiatriecongres 2025
Read More: Merck Animal Health
Related Post: PharmaShots Weekly Snapshots (Oct 13, 2025 – Oct 17, 2025)
